Company intelligence
IBSA Group
About IBSA Group
IBSA Institut Biochimique SA is a privately owned pharmaceutical company founded in Lugano in 1945. It started to develop its specific identity in 1985, when the current management took over, redefining its strategy and focusing on developing technologies that improve the quality of existing therapeutic solutions. Today, it is present on 5 continents and over 90 countries. The Group now counts on 20 subsidiaries in Europe, China and USA, and boasts a product portfolio covering 10 therapeutic areas. The company employs over 2,500 people, distributed among its headquarters, subsidiaries and manufacturing sites. IBSA is one of the four largest operators worldwide in the area of Reproductive Medicine and one of the world's leaders in hyaluronic acid-based products. Therapeutic areas: 🔹 Reproductive Medicine 🔹 Endocrinology 🔹 Pain and Inflammation 🔹 Osteoarticular 🔹 Aesthetic Medicine 🔹 Dermatology 🔹 Uro-gynaecology 🔹 Cardiometabolic 🔹 Respiratory 🔹 Consumer Health
Verified activity
Signals from IBSA Group
4 published signals
Presence & Recognition
IBSA Group is attending the 14th European Congress of Andrology (ECA 2026) in Modena, Italy, from 16 to 18 September 2026.
Reported by IBSA Group
Operations & Supply
IBSA Group has a production site located in Lodi, Italy, since 2001.
Reported by IBSA Group
Presence & Recognition
IBSA Group contributed to the international scientific debate on the future of hypothyroidism treatment at the 47th Congress of the European Thyroid Association (ETA) with a focus on precision medicine and personalised treatment.
Reported by IBSA Group
People
IBSA Group is hiring professionals to bring their experience and initiative to the team.
Reported by IBSA Group